Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • Estrogen Receptor/ERR
    (6)
  • Drug Metabolite
    (4)
  • Estrogen/progestogen Receptor
    (3)
  • Aromatase
    (1)
  • Cytochromes P450
    (1)
  • E3 Ligase Ligand-Linker Conjugate
    (1)
  • Endogenous Metabolite
    (1)
  • Parasite
    (1)
  • VEGFR
    (1)
  • Others
    (4)
Filter
Search Result
Results for "

4'hydroxy tamoxifen

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    8
    TargetMol | All_Pathways
4-Hydroxytamoxifen
trans-4-Hydroxytamoxifen, ICI 79280, (Z)-4-hydroxy Tamoxifen
T442068047-06-3
4-Hydroxytamoxifen (ICI 79280) is the active metabolite of Tamoxifen, an estrogen receptor modulator (SERM) with selective and oral potency. 4-Hydroxytamoxifen has antitumor activity and may be used in breast cancer research.
  • $64
In Stock
Size
QTY
TargetMol | Inhibitor Hot
TargetMol | Citations Cited
4'-hydroxy Tamoxifen
T2251282413-23-8
It is a metabolite of tamoxifen and an estrogen receptor modulator.
  • $415
35 days
Size
QTY
(E)-4-Hydroxytamoxifen
T15186174592-47-3
(E)-4-Hydroxytamoxifen is a less active isomer of (Z)-4-hydroxytamoxifen and also is an estrogen receptor modulator.
  • $82
5 days
Size
QTY
(E/Z)-4-Hydroxytamoxifen
Afimoxifene, 4-Hydroxytamoxifen
T674368392-35-8
(E/Z)-4-Hydroxytamoxifen (Afimoxifene) is a novel estrogen inhibitor, commonly used in research for various estrogen-dependent conditions, including cyclic mastalgia and gynecomastia.
  • $47
In Stock
Size
QTY
TargetMol | Citations Cited
Endoxifen
(E/Z)-N-desmethyl-4-hydroxy Tamoxifen, (E/Z)-Endoxifen
T4281110025-28-0
(E/Z)-Endoxifen ((E/Z)-Endoxifen) is an active metabolite of tamoxifen produced by the sequential action of cytochrome P450 (CYP) isoforms, including CYP2D6. It is a strong anti-estrogen, as it has an approximately 100-fold greater affinity for estrogen receptors than tamoxifen. As the efficient conversion of tamoxifen to endoxifen depends on CYP2D6, polymorphisms in this CYP isoform can impact the effectiveness of TMX treatment.
  • $39
In Stock
Size
QTY
TargetMol | Citations Cited
4'-Hydroxytamoxifen TFA
T201564
4'-Hydroxytamoxifen TFA, a salt form of a metabolite of Tamoxifen, demonstrates higher affinity for ER compared to Tamoxifen itself. This compound induces non-apoptotic cytotoxicity in human endometrial adenocarcinoma cells.
  • Inquiry Price
Inquiry
Size
QTY
SIM010603
T715761032265-67-0
SIM010603 is a structurally novel, oral, multi-targeted receptor tyrosine kinase inhibitor. SIM010603 inhibited stem cell factor receptor (Kit), vascular endothelial growth factor receptor-2 (VEGFR-2), platelet-derived growth factor receptor-β (PDGFR-β), glial cell line-derived neurotrophic factor receptor (Rearranged during Transfection; RET), and Fms-like tyrosine kinase-3 (FLT3) with IC(50) values between 5.0 and 68.1 nmol/l. SIM010603 inhibited the phosphorylation of PDGFR-β and VEGFR-2. Moreover, SIM010603 inhibited endothelial cell proliferation, endothelial cells chemotaxis, and corneal angiogenesis.
  • $1,820
8-10 weeks
Size
QTY
Norendoxifen
T710101308808-22-1
Norendoxifen, also known as 4-hydroxy-N, N-didesmethyltamoxifen, is a nonsteroidal aromatase inhibitor of the triphenylethylene group that was never marketed. It is an active metabolite of the selective estrogen receptor modulator tamoxifen.
  • $1,520
6-8 weeks
Size
QTY